Abstract:This study evaluates sulfonate‐based copolymers for anticoagulant therapy. It highlights the efficacy and safety of poly(ethylene glycol)47‐poly(sodium styrenesulfonate)32 which demonstrates high anticoagulant activity with a favorable safety profile. This copolymer shows the reversible anticoagulant effect, mainly targets factor XII and fibrinogen, and has the potential for both intravenous and subcutaneous administration. This novel copolymer offers promise in thrombotic disorder treatment. Despite targeting different coagulation cascade sites, all Food and Drug Administration‐approved anticoagulants present an elevated risk of bleeding, including potentially life‐threatening intracranial hemorrhage. Existing studies have not thoroughly investigated the efficacy and safety of sulfonate polymers in animal models and fully elucidate the precise mechanisms by which these polymers act. The activity and safety of sulfonated di‐ and triblock copolymers containing poly(sodium styrenesulfonate) (PSSS), poly(sodium 2‐acrylamido‐2‐methylpropanesulfonate) (PAMPS), poly(ethylene glycol) (PEG), poly(sodium methacrylate) (PMAAS), poly(acrylic acid) (PAA), and poly(sodium 11‐acrylamidoundecanoate) (PAaU) blocks are synthesized and assessed. PSSS‐based copolymers exhibit greater anticoagulant activity than PAMPS‐based ones. Their activity is mainly affected by the total concentration of sulfonate groups and molecular weight. PEG‐containing copolymers demonstrate a better safety profile than PAA‐containing ones. The selected copolymer PEG47‐PSSS32 exhibits potent anticoagulant activity in rodents after subcutaneous and intravenous administration. Heparin Binding Copolymer (HBC) completely reverses the anticoagulant activity of polymer in rat and human plasma. No interaction with platelets is observed. Selected copolymer targets mainly factor XII and fibrinogen, and to a lesser extent factors X, IX, VIII, and II, suggesting potential application in blood‐contacting biomaterials for anticoagulation purposes. Further studies are needed to explore its therapeutic applications fully.

A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis

STuning Blood‐Material Interactions to Generate Versatile Hemostatic Powders And Gels

Non-cross-linked collagen type I microfibers for improved hemostasis and wound healing

Synthesis, Biological Evaluation and Reversal of Sulfonated Di‐ and Triblock Copolymers as Novel Parenteral Anticoagulants

Sequential‐Crosslinking Fibrin Glue for Rapid and Reinforced Hemostasis

Co-assembled biomimetic fibrils from collagen and chitosan for performance-enhancing hemostatic dressing

Gluing blood into adhesive gel by oppositely charged polysaccharide dry powder inspired by fibrin fibers coagulation mediator

A sodium alginate - silk fibroin biosponge loaded with thrombin: Effective hemostasis and wound healing

Highly Efficient Hemostatic Cross-Linked Polyacrylate Polymer Dressings for Immediate Hemostasis

Chemical Adjustment of Fibrinolysis

Glutaraldehyde Cross-Linking of Salt-Induced Fibrinogen Hydrogels

Zeolite-fibrin Clot Composite As a Haemostatic Agent for Haemophilia A.

Preparation and hemostatic property of low molecular weight silk fibroin

Dynamic dual-crosslinking antibacterial hydrogel with enhanced bio-adhesion and self-healing activities for rapid hemostasis in vitro and in vivo

Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa

A Self‐Assembly Pro‐Coagulant Powder Capable of Rapid Gelling Transformation and Wet Adhesion for the Efficient Control of Non‐Compressible Hemorrhage

Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen

A Nanostructured Synthetic Collagen Mimic for Hemostasis

PCL-based and Hirudin-containing Composite Nanofibers for Prolonged Anticoagulation Effect

Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A

Polydopamine-Coated Polycaprolactone Electrospun Nanofiber Membrane Loaded with Thrombin for Wound Hemostasis